Choong Jonathan W, Ou Ruchong, Lim Yi Wee, Rosenfeldt Franklin L
1 Department of Cardiothoracic Surgery, Cardiac Surgical Research Unit, Alfred Hospital and the Department of Surgery, Monash University, Melbourne, Australia.
Transplantation. 2016 Mar;100(3):546-53. doi: 10.1097/TP.0000000000000926.
We previously showed that donation after circulatory death (DCD) canine hearts can be resuscitated if perfused with warm blood. However, clinical application of this technique is complex and difficult. We have developed a simplified system of cold crystalloid perfusion and compared it with standard cold storage for DCD heart preservation.
Anesthetized greyhounds underwent 30 minutes DCD by withdrawal of ventilation followed by assignment to either 4 hours of perfusion (n = 6) or cold storage (n = 7). Nonpreserved hearts (n = 5) served as a normal reference group. Perfusion hearts were reperfused with a protective solution then perfused for 4 hours with a novel oxygenated, nutrient-containing solution at 20 mL/min at 4°C to 10°C. Cold storage hearts were flushed with St Thomas' cardioplegic solution and stored in ice. After preservation, the recovery of the hearts was assessed on a blood-perfused working heart rig.
During preservation, perfusion hearts consumed oxygen (0.09 ± 0.01 mL/100 g per minute) and showed decreasing lactate production in the perfusate (initial: 0.031 ± 0.004 vs final: 0.007 ± 0.002 mmol/min; P = 0.001). After preservation, compared to cold storage hearts, perfusion hearts had higher cardiac output (P = 0.004), LV dP/dt max (P = 0.003) and myocardial oxygen efficiency (P = 0.01), with lower blood perfusate lactate (P = 0.007). Hemodynamic values of perfused hearts reached 60% or more those in the normal reference group.
Continuous cold crystalloid perfusion in a canine model of DCD: (1) facilitates aerobic metabolism and resuscitates the DCD heart, (2) provides functional and metabolic recovery superior to cold storage, (3) shows promise for improved clinical preservation of DCD and marginal donor hearts.
我们之前表明,如果用温血灌注,循环死亡后捐赠(DCD)的犬心脏可以复苏。然而,这项技术的临床应用复杂且困难。我们开发了一种简化的冷晶体灌注系统,并将其与用于DCD心脏保存的标准冷藏方法进行了比较。
对麻醉后的灵缇犬进行30分钟的通气撤离以造成DCD,然后将其分为4小时灌注组(n = 6)或冷藏组(n = 7)。未保存的心脏(n = 5)作为正常参考组。灌注心脏先用一种保护溶液进行再灌注,然后在4°C至10°C下以20 mL/分钟的速度用一种新型的含氧、含营养物质的溶液灌注4小时。冷藏心脏用圣托马斯心脏停搏液冲洗后储存在冰中。保存后,在血液灌注的工作心脏模型上评估心脏的恢复情况。
在保存期间,灌注心脏消耗氧气(0.09±0.01 mL/100 g每分钟),灌注液中的乳酸生成减少(初始:0.031±0.004 vs最终:0.007±0.002 mmol/分钟;P = 0.001)。保存后,与冷藏心脏相比,灌注心脏的心输出量更高(P = 0.004),左心室dp/dt max更高(P = 0.003),心肌氧效率更高(P = 0.01),而血液灌注液中的乳酸更低(P = 0.007)。灌注心脏的血流动力学值达到正常参考组的60%或更高。
在DCD犬模型中进行连续冷晶体灌注:(1)促进有氧代谢并使DCD心脏复苏,(2)提供优于冷藏的功能和代谢恢复,(3)显示出改善DCD和边缘供体心脏临床保存的前景。